OmniAb (OABI) EBIT Margin (2022 - 2026)

OmniAb (OABI) reported EBIT Margin of 54.27% for Q1 2026, up 39937.0% year-over-year from N/an in Q1 2025, and up 71.17% quarter-over-quarter from 188.23% in Q4 2025.

OmniAb (OABI) EBIT Margin (2022 - 2026) Analysis & Trends

OmniAb (OABI) has 5 years of EBIT Margin data on file, last reported at 54.27% in Q1 2026.

  • EBIT Margin for Q1 2026 came in at 54.27%, up 39937.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 200.26% (up 6444.0% YoY), and the FY2025 annual result was 369.49%, down 8719.0% from the prior year.
  • EBIT Margin improved to 54.27% in Q1 2026 per OABI's latest filing, from 188.23% in the prior quarter.
  • Over five years, EBIT Margin peaked at 25.6% in Q4 2022 and troughed at 810.18% in Q3 2025.
  • A 5-year average of 290.69% and a median of 215.76% in 2022 frame the typical range for EBIT Margin.
  • The sharpest annual moves came in 2024 and 2026: EBIT Margin tumbled 54338 bps in 2024, then surged 39937 bps in 2026.
  • A 5-year view of EBIT Margin shows it stood at 25.6% in 2022, then sank by 1818 bps to 439.78% in 2023, then soared by 67 bps to 146.98% in 2024, then decreased by 28 bps to 188.23% in 2025, then jumped by 71 bps to 54.27% in 2026.
  • Business Quant data shows OABI's EBIT Margin at 54.27% in Q1 2026, 188.23% in Q4 2025, and 810.18% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -6.43%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 38.10%
9 Abivax 91.96 Bn 91.96 Bn - -
10 OmniAb 294.96 Mn 252.00 Mn 14.41 Mn -54.27%

Historic Data

Download Data
DateValue
Mar 31, 2026 -54.27%
Dec 31, 2025 -188.23%
Sep 30, 2025 -810.18%
Jun 30, 2025 -416.19%
Mar 31, 2025 -453.64%
Dec 31, 2024 -146.98%
Sep 30, 2024 -473.73%
Jun 30, 2024 -214.14%
Mar 31, 2024 -593.34%
Dec 31, 2023 -439.78%
Sep 30, 2023 -370.91%
Jun 30, 2023 -279.95%
Mar 31, 2023 -49.96%
Dec 31, 2022 25.60%
Sep 30, 2022 -215.76%
Jun 30, 2022 -174.55%
Mar 31, 2022 -85.66%